Activating Clinical Trial Sites Quickly During COVID-19 Lockdowns
A sponsor needed to enroll at least 200 patients for a pivotal Phase IIIb clinical trial — right when the…
Protocol Design Trends Investigators Should Look for When Selecting Studies
For investigative sites, selecting studies for increased patient centricity, whether through decentralized trials, patient input in study design, or remote…
Access to Patients = Exceeded Enrollment
See how Frenova’s clinical research sites, through rapid startup, leveraged relationships and site management achieved enrollment goals in less time…
Frenova Helps With Business, Allows Principal Investigator to Focus on Care
Clinical investigators regularly report that logistical barriers hinder their conduct of clinical trials. Physician and staff workload balance, the time…
Overcoming Barriers to Enrolling Renal Patients in Clinical Trials: Q&A With Kurt Mussina
Kurt Mussina, General Manager of Frenova Renal Research and Vice President of Clinical Studies Operations for Fresenius Medical Care North…
F1RST Up®: Accelerating Clinical Trial Start-Up
Despite the pressing need to bring novel therapies to patients with renal impairments, the development time and cost to bring…
Thinking About Adding Clinical Research to Your Practice? Here Are Five Things to Consider
Why Add Research to Your Practice? One business strategy physicians and medical groups often consider is adding clinical research to…
Prevent the Real World From Derailing Your Clinical Trial: Focus On Protocol Design
Clinical trial sponsors are continually seeking ways to improve the speed and efficiency of their clinical development projects. However, they…
Rapid Study Startup: Streamlining Trial Site Activation
The redundancy of processes and documentation is a major bottleneck in activating clinical trial sites. Rapid study startup (RSS) is…